The world of emerging medical technologies is vast and continuously evolving.<br /><br />Join host Charles Beasley as he discusses the future of medicine and human health with the best and brightest in these fields. <br /><br />New episodes weekly. <br /><br />#goodclinical #goodclinicalpodcast #goodclinicalnetwork #goodclinicalexplains #goodclinicalevents

Chat_GCP Podcast
Claim This Podcastby Charles Beasley
Podcast Authority
Beta
Podcast Overview
The world of emerging medical technologies is vast and continuously evolving.<br /><br />Join host Charles Beasley as he discusses the future of medicine and human health with the best and brightest in these fields. <br /><br />New episodes weekly. <br /><br />#goodclinical #goodclinicalpodcast #goodclinicalnetwork #goodclinicalexplains #goodclinicalevents
Language
🇺🇲
Publishing Since
8/23/2023
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Chat_GCP Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

January 20, 2025
Ep 43 - A/Prof Rodger Tiedemann - NZ's Medicines Deficit: Why are Kiwis Missing Out?
In this weeks episode I sit down with A/Prof Rodger Tiedemann, a Consultant Haematologist, A/Prof of Medicine, Researcher, and advocate for medicines access and clinical trials in New Zealand.<br /><br />We begin by chatting about Rodgers involvement in multiple myeloma research and the treatment landscape, and how targeted therapies have improved survival rates for this type of cancer.<br /><br />We then centre the discussion on the challenges facing New Zealand's healthcare system, particularly in terms of access to modern medicines and clinical trials.<br /><br />New Zealand's funding for medicines is significantly lower compared to other countries with comparative GDPs, and we have a large 10 year deficit in access to new cancer treatments for Kiwi patients.<br /><br />For example, we rank 30th in GDP per capita from 218 countries. By this measure of national income, we fall between Germany and the UK, and ahead of France, Italy and Japan. However, while those countries each reimbursed 119-165 new medicines between 2016-2021, New Zealand reimbursed only 17... This lack of access also impacts clinical trial availability, as trials often require patients to have already received standard-of-care treatments, which may not even be funded yet in New Zealand. Consequently, pharmaceutical companies are less inclined to bring clinical trials to NZ, further limiting options for our patients. So what needs to be done to fix this?<br /><br /> A significant frameshift in drug funding is critical for NZ. The valuation and budgeting of healthcare, increased funding for medicines, and the understanding of how this would benefit the NZ economy due to second- and third-order effects of new medicines (I.e., lower healthcare spending, faster time returning to work etc.). This would not only improve patient outcomes but also attract more clinical trials, which could also bring economic benefit.<br /><br />You can find out more about A/Prof Rodger Tiedemann here:<br />https://www.linkedin.com/in/rodger-tiedemann-a2306580/ <br /><br /> 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐊𝐄𝐘𝐖𝐎𝐑𝐃𝐒:- cancer treatment, blood cancers, multiple myeloma, immunotherapy, medicine access, New Zealand healthcare, clinical trials, haematology, cancer research

December 18, 2024
Ep 42 - Professor John Windsor - From Concept to Clinic: Innovating Post-Surgical Recovery
Professor John Windsor, a pioneering surgeon and researcher, shares insights on innovating post-surgical recovery with the Limpet device, a groundbreaking alternative to traditional drainage methods.

December 9, 2024
Ep 41 - Dr Patrick McHugh - Heart Rate Variability and its Role in Mental Health
Dr. Patrick McHugh, a general practitioner, explores how heart rate variability can be a key measure of mental health, linked to better adaptability and emotional resilience.
44 total episodes available
Recent guests on Chat_GCP Podcast
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Professor John Windsor
Guest
Deep-dive analytics for Chat_GCP Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Chat_GCP Podcast?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.